Academy of Military Medical Sciences
The Academy of Military Medical Sciences (AMMS) of the People's Liberation Army Academy of Military Sciences (Chinese: 中国人民解放军军事科学院军事医学研究院) is a Chinese military medical research institute. It was established in Shanghai in 1951. It has been based in Beijing since 1958.
| Academy of Military Medical Sciences | |||||||
|---|---|---|---|---|---|---|---|
| Simplified Chinese | 中国人民解放军军事科学院军事医学研究院 | ||||||
| Traditional Chinese | 中國人民解放軍軍事科學院軍事醫學研究院 | ||||||
| |||||||
In October 2011, the drug "Night Eagle", developed to help soldiers cope with sleep deprivation during missions, was unveiled in an exhibition marking the institute's 60th anniversary.
In December 2014, the Chinese government announced that the Academy of Military Medical Sciences had developed an Ebola virus vaccine candidate that had been approved for clinical trials.
In December 2021, the United States Department of Commerce added the Academy of Military Medical Sciences to the Entity List, accusing it of aiding in the persecution of Uyghurs in China.